The hemp industry may be entering healthcare pathways at the exact moment its regulatory runway narrows. Beginning April 1, 2026, the Center for Medicare and Medicaid Services (CMS) formally opened a new hemp-related pathway through the Substance Access Beneficiary Engagement Incentive (BEI) for participating Accountable Care Organizations (ACO) REACH and Enhancing Oncology Model (EOM) organizations. For hemp growers, processors and CBD brands, this […]
